Neurodegenerative diseases and disorders represent the largest challenge to the global healthcare system.
There is an unmet need for a passive measurement tool that can identify early indicators, differentiate among diseases, measure and predict progression over time and risk stratify patients.
A digital biomarker
No tests or special equipment
Typing cadence, not content
Install and forget
Easy to Install
Runs in background
NeuraMetrix TC has applications across a range of users, from patients and their caregivers to researchers creating new treatments.
Ongoing Global Research
Researchers at leading academic institutions around the world are using NeuraMetrix TC in research across a range of diseases and disorders.